| 1 |
Ben-arzi A, Ehrlich R, Neumann R. Retinal Diseases: The Next Frontier in Pharmacodelivery. Pharmaceutics 2022;14:904. [DOI: 10.3390/pharmaceutics14050904] [Reference Citation Analysis]
|
| 2 |
Yang B, Li G, Liu J, Li X, Zhang S, Sun F, Liu W. Nanotechnology for Age-Related Macular Degeneration. Pharmaceutics 2021;13:2035. [PMID: 34959316 DOI: 10.3390/pharmaceutics13122035] [Reference Citation Analysis]
|
| 3 |
Adachi H, Hengesbach M, Yu YT, Morais P. From Antisense RNA to RNA Modification: Therapeutic Potential of RNA-Based Technologies. Biomedicines 2021;9:550. [PMID: 34068948 DOI: 10.3390/biomedicines9050550] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 4 |
Anthony K. RNA-based therapeutics for neurological diseases. RNA Biol 2022;19:176-90. [PMID: 35067193 DOI: 10.1080/15476286.2021.2021650] [Reference Citation Analysis]
|
| 5 |
Sanghani A, Andriesei P, Kafetzis KN, Tagalakis AD, Yu-Wai-Man C. Advances in exosome therapies in ophthalmology-From bench to clinical trial. Acta Ophthalmol 2021. [PMID: 34114746 DOI: 10.1111/aos.14932] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Moumné L, Marie A, Crouvezier N. Oligonucleotide Therapeutics: From Discovery and Development to Patentability. Pharmaceutics 2022;14:260. [DOI: 10.3390/pharmaceutics14020260] [Reference Citation Analysis]
|
| 7 |
Rasoulinejad SA, Maroufi F. CRISPR-Based Genome Editing as a New Therapeutic Tool in Retinal Diseases. Mol Biotechnol 2021;63:768-79. [PMID: 34057656 DOI: 10.1007/s12033-021-00345-4] [Reference Citation Analysis]
|
| 8 |
Zuzic M, Striebel J, Pawlick JS, Sharma K, Holz FG, Busskamp V. Gene-independent therapeutic interventions to maintain and restore light sensitivity in degenerating photoreceptors. Prog Retin Eye Res 2022;:101065. [PMID: 35562270 DOI: 10.1016/j.preteyeres.2022.101065] [Reference Citation Analysis]
|
| 9 |
Zhang J, Jiao J, Niu M, Gao X, Zhang G, Yu H, Yang X, Liu L. Ten Years of Knowledge of Nano-Carrier Based Drug Delivery Systems in Ophthalmology: Current Evidence, Challenges, and Future Prospective. Int J Nanomedicine 2021;16:6497-530. [PMID: 34588777 DOI: 10.2147/IJN.S329831] [Reference Citation Analysis]
|
